NEAT1 and Alzheimer disease: A recent study showed lncRNA NEAT1 level was significantly higher in the temporal cortex and hippocampus of AD patients, indicating that NEAT1 was a biomarker for AD diagnosis (Spreafico et al., 2018[34]).